Ajix, Inc. – Trademark Portfolio
Entity Type: 03
Ajix, Inc. holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 9 filings in this category. The portfolio also extends into Class 40 (Treatment & Processing) across 4 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include AJIX, G-CAPS, LYFE GROUP, THE NATURAL CHOICE FOR QUALITY, and K-CAPS DELAYED RELEASE CAPSULES. The owner is based in Pompano Beach, FL.
1893 SW Third Street
Pompano Beach, FL 33069
Showing of trademarks Trademarks
Trademark Classifications
Ajix, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does Ajix, Inc. have?
Ajix, Inc. has 10 U.S. trademarks filed with the USPTO. Of these, 6 registered, 4 abandoned.
What trademark classes does Ajix, Inc. file in?
Ajix, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Ajix, Inc.'s most well-known trademarks?
Ajix, Inc.'s registered trademark portfolio includes well-known marks such as AJIX, G-CAPS, LYFE GROUP, THE NATURAL CHOICE FOR QUALITY, and K-CAPS DELAYED RELEASE CAPSULES. These are among 6 currently registered trademarks in the portfolio.
What is Ajix, Inc.'s trademark registration success rate?
Ajix, Inc. has a 60% trademark registration rate, with 6 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.